"This is brilliant news. I have been lobbying Pharma for years to take MS-spasticty seriously. I must spend a good 10-15% of my clinical activities managing spasticity and dealing with the side effects of the current agents that are appalling. I am sure that any new anti-spastic drug with a better side effect profile and similar efficacy to current runners will be a block-buster drug. If you have advanced MS and suffer from spasticity you should be cheering and celebrating this news."
"Thank you FastForward, you are doing a great job!"